Digital Making sense of differing digital health funding reports Digital health venture funding had a ridiculous, bonkers, blockbuster year.
Views & Analysis US loses, EU wins as Chinese biotech investment shifts focus Chinese biotech investors are taking an interest in the European market as diplomatic relations with the US become strained.
News Zymeworks cuts deal to buy Theravance for $929m in cash Zymeworks has reached a deal to buy Theravance, claiming rights to COPD therapy Yupelri, sold by Viatris, which made $267m last year.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
